Oncode Accelerator is a public-private program which aims to innovate and accelerate the development of new cancer therapies by placing cancer patients at the core of preclinical therapy development. This is realized through the power of three innovation platforms: Patient Cohorts, Organoids and Artificial Intelligence.

We leverage the full potential of the Dutch innovation ecosystem by building preclinical development pipelines for cancer therapies.

If you have a suitable preclinical lead candidate that can benefit from one of the innovation platforms, you might be eligible for co-funding through the program, so come and find us at I4H to discuss.